(Reuters) – The U.S. Centers for Disease Control and Prevention reported Thursday that 4.4 million people have received updated booster doses of COVID-19, just weeks after the government’s new vaccination campaign.
The US has begun rolling out shots specifically designed for Omicron from Pfizer/BioNTech and Moderna (NASDAQ 🙂 earlier this month.
More than 25 million doses of so-called bivalent injections have been dispatched, a federal health agency said Tuesday. This consists mostly of the Pfizer/BioNTech vaccine, with production of the Moderna vaccine increasing.
The redesigned enhancers are intended to address the BA.5 and BA.4 Omicron sub-variables, which make up 84.8% and 1.8%, respectively, of all variants circulating in the United States, based on the most recent data.